The Evaluation of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Initial Staging in Intermediate-Risk Prostate Cancer Patients: A Retrospective Multicenter Analysis
PSMA PET/CT can affect the management of patients with intermediate-risk PCa in up to 13% of cases, mainly for unfavorable diseases. New imaging techniques as a first-line imaging procedure can help to plan the correct therapeutic approach in the intermediate-risk PCa group.
Authors
- Vittorio Fasulo (ORCID: https://orcid.org/0000-0001-6155-5964)
- Giulia Giacoppo
- Marcello Rodari (ORCID: https://orcid.org/0000-0002-9419-8964)
- Lucia Setti (ORCID: https://orcid.org/0000-0002-7035-0511)
- Giovanni Lughezzani (ORCID: https://orcid.org/0000-0003-3939-4521)
- Massimo Lazzeri (ORCID: https://orcid.org/0000-0002-4411-3715)
- Nicolò Maria Buffi (ORCID: https://orcid.org/0000-0003-2436-9091)
- Demetrio Aricò (ORCID: https://orcid.org/0000-0002-5798-9943)
- A. Salvaggio
- Lorenzo Muraglia (ORCID: https://orcid.org/0000-0002-8508-8368)
- Priscilla Guglielmo (ORCID: https://orcid.org/0000-0001-9150-4367)
- Katia Marzo
- Jelena Jandric
- Manuela Bonacina (ORCID: https://orcid.org/0000-0003-2940-2460)
- Laura Evangelista (ORCID: https://orcid.org/0000-0002-5955-9488)
Institutions
- Humanitas University (IT)
- Humanitas Gavazzeni (IT)
- Humanitas Mater Domini (IT)
- Fondazione Humanitas per la Ricerca (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Diagnostics
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3390/diagnostics14232751
- Citations
- 6
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.51
Funders
- Humanitas Research Hospital